H1B Salary Data

Home › Employers › Lykan Bioscience Holdings LLC

Lykan Bioscience Holdings LLC: H-1B salaries and sponsorship

Lykan Bioscience Holdings LLC filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $130,000.

Applications (LCAs)3
Certified3
Employer addressHopkinton, MA
H-1B dependent employerNo
Median offered salary$130,000
Middle half of salaries$127,500–$132,500
10th–90th percentile$126,000–$134,000

Does Lykan Bioscience Holdings LLC sponsor H-1B visas?

Lykan Bioscience Holdings LLC filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 18, 2023. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Software Test Manager1$135,000
Project Manager II1$130,000
CSV Engineer1$125,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20232$127,500
FY20241$135,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
CSV Engineer$125,000–$135,000
Level II
Wakefield, MAApr 18, 2023Apr 24, 2023Certified
Project Manager II$130,000–$140,000
Level III
Hopkinton, MAFeb 27, 2023Mar 13, 2023Certified
Software Test Manager$135,000–$145,000
Level II
Hopkinton, MADec 15, 2022Jan 9, 2023Certified, then withdrawn

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).